1-8 of 8
Uwe Klueppelberg, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Junctional Adhesion Molecule-A/F11 Receptor (JAM-A/F11R) Is a Novel Biomarker and a Potential Treatment Target In Multiple Myeloma Tumor and Its Microvascular Milieu

Bani M Azari, MD/PhD, Danielle F Joseph, PhD, Marc J Braunstein, MD/PhD, H. Uwe Klueppelberg, MD, Eric LP Smith, PhD, Sadeaqua Scott, PhD, Jonathan D Marmur, MD, Anna Babinska, PhD, Olcay Batuman, MD
Journal: Blood
Blood (2010) 116 (21): 450.
https://doi.org/10.1182/blood.V116.21.450.450
Published: 2010
Journal Articles

Endothelial Progenitor Cells within the Bone Marrow Microenvironment of Multiple Myeloma Patients Display Stem Cell Traits.

Sadeaqua S. Scott, BS, Marc J. Braunstein, BS, Christopher Lange, PhD, Christopher Roman, PhD, Uwe Klueppelberg, MD, Olcay Batuman, MD
Journal: Blood
Blood (2009) 114 (22): 2816.
https://doi.org/10.1182/blood.V114.22.2816.2816
Published: 2009
Journal Articles

Targeting Hsp70 in Multiple Myeloma Induces Synergistic Cytotoxicity with Inhibitors of the Proteasome and of Hsp90

Marc J Braunstein, Craig M Scott, Shannon Behrman, Peter Walter, PhD, Peter Wipf, PhD, Eric LP Smith, PhD, Sadeaqua S Scott, BA, H. Uwe Klueppelberg, MD, Jeffrey L Brodsky, PhD, Olcay Batuman, MD
Journal: Blood
Blood (2008) 112 (11): 5160.
https://doi.org/10.1182/blood.V112.11.5160.5160
Published: 2008
Journal Articles

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Zoledronate, Dexamethasone, and Low-Dose Thalidomide: A Phase II Trial.

Uwe Klueppelberg, MD, PhD, Eric L.P. Smith, PhD, Marc J. Braunstein, MD, PhD candidate, David Kahn, MD, Olcay A. Batuman, MD
Journal: Blood
Blood (2006) 108 (11): 5124.
https://doi.org/10.1182/blood.V108.11.5124.5124
Published: 2006
Journal Articles

Differential Effects of Hsp70 Inhibition within the Tumor and Microenvironment in Multiple Myeloma.

Marc J. Braunstein, MD, PhD, Na Liu, MD, Uwe Klueppelberg, MD,PhD, Craig Scott, Shannon Behrman, Can Tamucin, Peter Walter, PhD, Peter Wipf, PhD, Jeffrey Brodsky, PhD, Olcay Batuman, MD
Journal: Blood
Blood (2006) 108 (11): 5070.
https://doi.org/10.1182/blood.V108.11.5070.5070
Published: 2006
Journal Articles

Treatment of Newly Diagnosed, Inner-City Multiple Myeloma Patients with Low-Dose Thalidomide in Combination with Dexamethasone and Zoledronate: A Phase II Trial.

Uwe Klueppelberg, MD, PhD, Iuliana Shapira, MD, Eric Smith, PhD, Marc Braunstein, BS, David Kahn, MD, Yury Pertsovsky, Olcay Batuman, MD
Journal: Blood
Blood (2005) 106 (11): 5180.
https://doi.org/10.1182/blood.V106.11.5180.5180
Published: 2005
Journal Articles

Evidence for Clonality in Circulating Endothelial Progenitor Cells in Multiple Myeloma.

Tayfun Ozcelik, MD, Varsha Vakil, Eric Smith, PhD, Marc Braunstein, Justin Maroney, Uwe Klueppelberg, MD PhD, Sevgi Bagislar, Cemaliye Akyerli, Olcay Batuman, MD
Journal: Blood
Blood (2004) 104 (11): 2357.
https://doi.org/10.1182/blood.V104.11.2357.2357
Published: 2004
Journal Articles

First-Line Treatment of Multiple Myeloma with a Combination of Thalidomide, Dexamethasone, and Zoledronate (TDZ) in an Inner-City Population with High HIV Prevalence.

Uwe Klueppelberg, MD PhD, Eric Smith, PhD, Laurie Chen, MD, Chona M. Aloba, MD, Iuliana Shapira, MD, Mehdi M. Moezi, MD, Olcay Batuman, MD
Journal: Blood
Blood (2004) 104 (11): 4932.
https://doi.org/10.1182/blood.V104.11.4932.4932
Published: 2004